Active — Not RecruitingNot Applicable

Microneedling Versus Carboxytherapy in Stria Distensae Rubra

Egypt50 participantsStarted 2022-10-01

Plain-language summary

The aim of this study is to evaluate and compare the efficacy and safety of microneedling and carboxytherapy either with or without platelet-rich plasma in the treatment of striae distensae rubra.

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Female patients. * Age ranging from 18-45 years old. * Fitzpatrick skin type III-IV. * Striae distensae rubra on the abdomen (bilateral and more or less symmetrical). Exclusion Criteria: * Patients taking immunosuppressants or having any disease affecting wound healing including diabetes. * Patients receiving systemic glucocorticoids for chronic health conditions. * Patients with chronic dermatologic diseases such as psoriasis and vitiligo. * Pregnant and lactating females. * Patients with a tendency for keloid formation. * Patients with endocrine disturbance. * Patients with autoimmune diseases, systemic diseases such as severe anemia, respiratory, cardiac, renal or liver disorder. * Patients with bleeding and coagulation disorders. * Patients who received any form of treatment for their SD in the past 6 months.

What they're measuring

Reduction in the size of the stria distensae rubra

Timeframe: group I: six sessions over 18 weeks , group II: 6 sessions over 12 weeks, followed in both groups by three months of follow up

Trial details

NCT IDNCT07001644

SponsorAlexandria University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-10

View on ClinicalTrials.gov More Striae Distensae trials